IBM Mainframe MLC and IPLA Negotiation Service: Reduce Your Largest Fixed IT Cost

The Challenge: IBM Mainframe Costs That Grow Without Intervention

IBM mainframe S&S charges rise 3–5% per year automatically. MLC costs increase every time your R4HA peak climbs — and IBM will not reduce billing unless actively challenged with SCRT data and a commercial negotiation. Most enterprises accept these increases as fixed costs. They are not. Monthly License Charge products — including z/OS, Db2 for z/OS, CICS, IMS, and MQ for z/OS — are billed monthly based on the Rolling 4-Hour Average (R4HA) peak MSU consumption. If your workload increases, your MLC bill increases automatically, with no capacity ceiling unless explicitly negotiated. For organisations running batch-heavy workloads, a single month with elevated batch activity can set a peak that drives charges for months afterward.

International Program License Agreement products carry perpetual licences with annual Subscription and Support (S&S) charges. IBM increases S&S rates annually, typically 3 to 5 percent, without requiring any negotiation. Many organisations simply absorb these increases year after year, treating mainframe software costs as a fixed line item rather than a negotiable commercial relationship.

Both cost structures can be reduced — but doing so requires specialist knowledge of IBM's commercial framework, access to peer pricing benchmarks, and a negotiation strategy that IBM's sales teams are not designed to deliver voluntarily.

Our IBM Mainframe MLC and IPLA Negotiation Service

Redress Compliance's mainframe negotiation service is delivered in three phases, covering analysis, strategy, and commercial execution.

Phase 1: SCRT Data Analysis and Cost Modelling (Weeks 1–3)

The foundation of any IBM mainframe negotiation is the Sub-Capacity Reporting Tool (SCRT) data. SCRT reports capture MSU consumption across all logical partitions (LPARs) and provide the R4HA peak data that determines current MLC charges. We conduct a comprehensive 12-month SCRT analysis to identify the following:

• Current R4HA peaks by product and LPAR, and the workloads driving them
• Trend analysis showing whether peaks are increasing, stable, or declining
• Identification of batch and workload scheduling opportunities that could reduce peak MSU without impacting service levels
• Tailored Fit Pricing (TFP) modelling under both the Enterprise Consumption and Enterprise Capacity solutions, compared against current MLC billing
• IPLA product inventory with S&S charge breakdown and assessment of products that are decommissioned or minimally used

The ILMT framework for distributed IBM products is separate from mainframe SCRT — we verify that any distributed IBM software components co-deployed with mainframe applications are correctly covered under ILMT sub-capacity reporting, ensuring no compliance exposure is introduced through the cost optimisation work. Sub-capacity licensing for distributed components requires continuous ILMT operation, and any gap creates risk that must be identified before entering IBM negotiations.

Phase 2: Negotiation Strategy Development (Weeks 3–5)

Armed with the SCRT analysis and cost model, we develop a customised negotiation strategy that identifies the optimal IBM commercial structure for your organisation. This strategy covers three dimensions:

Technical optimisation: Workload scheduling recommendations that reduce R4HA peaks without impacting critical batch and online transaction processing. For organisations running on IBM Z hardware approaching refresh, we model the technology dividend — the MSU reduction delivered by newer hardware generations — and incorporate it into the cost forecast.

Commercial structure: Recommendation on whether to pursue traditional MLC optimisation, Tailored Fit Pricing (TFP), an Enterprise License Agreement (ELA) covering both mainframe and distributed products, or a combination of these approaches. For organisations with significant IBM software spend beyond mainframe (Db2, MQ, WebSphere on distributed platforms), a bundled ELA negotiation often delivers better overall pricing than a standalone mainframe negotiation.

Timing strategy: IBM's fiscal year ends December 31. Negotiations timed to conclude in Q4 benefit from IBM's year-end commercial pressure and consistently achieve better pricing than mid-year negotiations. Where possible, we align negotiation timelines to IBM's internal quota cycles.

Phase 3: IBM Commercial Negotiation (Weeks 5–8)

We represent your organisation in direct commercial discussions with IBM, bringing independent benchmark data, technical cost modelling, and negotiation experience from 80+ IBM mainframe engagements. Our negotiation representation covers the following areas:

For MLC products, we negotiate the baseline MSU schedule, Tailored Fit Pricing contract terms (if applicable), development and test capacity inclusions, growth bucket pricing, and multi-year rate stability commitments. For organisations transitioning to TFP for the first time, we negotiate the baseline MSU and workload allocation that determines the starting point of the new arrangement — this baseline negotiation is critical, as a high baseline permanently elevates costs under TFP.

For IPLA products, we negotiate S&S rate reductions or freezes, identify products eligible for S&S termination (decommissioned software), and where applicable, negotiate licence metric conversions that better align with actual usage patterns. The PVU-to-VPC transition has created opportunities to renegotiate IPLA metric structures for some distributed mainframe-adjacent products — we assess whether any of your IPLA entitlements were migrated to VPC and whether the metric migration was executed correctly.

What Our Clients Achieve

Across 80+ IBM mainframe negotiation engagements, our clients have achieved the following outcomes:

• MLC cost reductions of 15 to 30 percent through a combination of TFP adoption, R4HA reduction, and renegotiated MLC schedules.
• IPLA S&S savings of 8 to 20 percent through S&S termination of decommissioned products and S&S rate renegotiation on strategic products.
• Development and test capacity inclusions that eliminate or significantly reduce the cost of running mainframe software in non-production environments — IBM's standard approach is to charge full MLC for development environments, while TFP and ELA arrangements routinely include no-charge or discounted dev/test capacity.
• Multi-year rate stability that protects against IBM's annual price increase programme and provides budget predictability for IT planning cycles.

Who This Service Is For

Our IBM Mainframe MLC and IPLA Negotiation Service is designed for enterprise organisations with significant IBM mainframe software spend — typically $2 million or more in annual MLC and IPLA costs. It is most valuable for organisations facing an IBM renewal in the next 6 to 18 months, those considering a Tailored Fit Pricing transition for the first time, those that have experienced MLC cost growth driven by workload increases, and organisations where IBM mainframe costs have been treated as non-negotiable line items and have been absorbing annual increases without commercial challenge.

Why Independent Advisory Matters

IBM's mainframe sales organisation is highly experienced, well-resourced, and commercially motivated. IBM's account teams negotiate dozens of large mainframe transactions every year, and they operate from a position of significant information asymmetry — they know what comparable customers pay, and they know what IBM is prepared to accept. Without independent advisory support, IBM's customers negotiate without benchmark data, without a prepared commercial position, and without the institutional knowledge of IBM's internal commercial decision-making that experience provides.

Redress Compliance operates exclusively on the buyer side. We carry no IBM reseller relationship, no IBM referral arrangement, and no conflict of interest that could compromise the independence of our advice. Our sole objective is to reduce your IBM mainframe costs while protecting your compliance position.